Continuous aerosol therapy system using a modified Collison nebulizer

Area of Science:

• Pharmacology
• Aerosol Science
• Virology

Background:

• Influenza virus infections pose a significant public health challenge.
• Effective delivery of antiviral compounds is crucial for treatment efficacy.
• Accurate and reproducible aerosol administration is needed for preclinical studies.

Purpose of the Study:

• To develop and validate a modified Collison nebulizer system for controlled aerosol delivery of antiviral agents.
• To establish a predictive model for aerosol concentration based on fluid properties and nebulizer settings.
• To optimize drug dosing for influenza virus treatment in a murine model.

Main Methods:

• Modification of a Collison nebulizer to control aerosol output via liquid feed rate adjustment.
• Development of a multiple regression equation using uranine dye to quantify aerosol concentration.
• Assessment of evaporative losses in the test solution over extended operation periods.
• Application of derived relationships to determine drug concentrations for specific doses.

Main Results:

• A functional exposure system for continuous antiviral aerosol administration to mice was established.
• A predictive equation accurately defined aerosol concentration as a function of dye concentration and nebulization rate.
• Evaporative losses were quantified, allowing for concentration adjustments.
• The system's performance was validated using the antiviral drug ribavirin.

Conclusions:

• The modified Collison nebulizer system provides a reliable method for controlled aerosol delivery of antiviral compounds.
• The developed regression model enables precise determination of drug concentrations for targeted dosing in preclinical influenza studies.
• This approach enhances the accuracy and reproducibility of aerosolized drug administration in animal models.